141 related articles for article (PubMed ID: 1838766)
1. Amplifier function of resistance vessels and the left ventricle in hypertension.
Korner PI; Angus JA; Bobik A; Jennings GL
J Hypertens Suppl; 1991 Dec; 9(2):S31-40; discussion S40-1. PubMed ID: 1838766
[TBL] [Abstract][Full Text] [Related]
2. Are cardiac and vascular "amplifiers" both necessary for the development of hypertension?
Korner PI; Bobik A; Angus JJ
Kidney Int Suppl; 1992 Jun; 37():S38-44. PubMed ID: 1385838
[TBL] [Abstract][Full Text] [Related]
3. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension.
Korner PI; Bobik A; Jennings GL; Angus JA; Anderson WP
J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S25-32. PubMed ID: 1715480
[TBL] [Abstract][Full Text] [Related]
4. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function.
Adams MA; Bobik A; Korner PI
Hypertension; 1989 Aug; 14(2):191-202. PubMed ID: 2527201
[TBL] [Abstract][Full Text] [Related]
5. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
Friberg P
Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Black MJ; Kanellakis P; Bobik A
J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
[TBL] [Abstract][Full Text] [Related]
8. Resistance control in hypertension.
Korner PI; Bobik A; Angus JA; Adams MA; Friberg P
J Hypertens Suppl; 1989 Sep; 7(4):S125-34; discussion S135. PubMed ID: 2681590
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Minami N; Head GA
J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of vascular resistance properties in hypertension. Haemodynamic and model analysis.
Korner PI; Angus JA
J Vasc Res; 1992; 29(4):293-312. PubMed ID: 1391553
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and vascular structural adaptation in experimental hypertension.
Friberg P; Adams MA
Eur Heart J; 1990 Nov; 11 Suppl G():65-71. PubMed ID: 2150038
[TBL] [Abstract][Full Text] [Related]
12. Effect of antihypertensive therapy on the cardiovascular amplifiers.
Korner PI; Adams MA; Jennings GL; Bobik A
Clin Exp Pharmacol Physiol; 1988 Mar; 15(3):191-7. PubMed ID: 2978739
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
Strauer BE
Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
[TBL] [Abstract][Full Text] [Related]
14. Influence of early antihypertensive treatment on vascular and cardiac design in SHR with and without renal hypertension.
Friberg P; Wåhlander H; Nordlander M
Blood Press; 1992 Oct; 1(3):173-80. PubMed ID: 1345051
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
Frohlich ED
Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
[TBL] [Abstract][Full Text] [Related]
16. Effects of lisinopril upon cardiac hypertrophy, central and peripheral hemodynamics and neurohumoral factors in spontaneously hypertensive rats.
Nishimura H; Kubota J; Okabe M; Ueyama M; Kawamura K
J Hypertens; 1992 May; 10(5):431-6. PubMed ID: 1317903
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes.
Korner PI; Jennings GL; Esler MD; Anderson WP; Bobik A; Adams M; Angus JA
Can J Physiol Pharmacol; 1987 Aug; 65(8):1730-8. PubMed ID: 2961426
[TBL] [Abstract][Full Text] [Related]
18. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
Brilla CG; Matsubara L; Weber KT
Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular hypertrophy and hypertension: causes and consequences.
Korner PI
Blood Press Suppl; 1995; 2():6-16. PubMed ID: 7582077
[TBL] [Abstract][Full Text] [Related]
20. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
Motz W; Strauer BE
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
